logo

AMPH

Amphastar·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

AMPH fundamentals

Amphastar (AMPH) released its earnings on Nov 6, 2025: revenue was 191.84M (YoY +0.33%), beat estimates; EPS was 0.93 (YoY -3.13%), beat estimates.
Revenue / YoY
191.84M
+0.33%
EPS / YoY
0.93
-3.13%
Report date
Nov 6, 2025
AMPH Earnings Call Summary for Q3,2025
  • Revenue Growth: Q3 2025 net revenues $191.8M,-backed by 14% BAQSIMI and 11% Primatene MIST growth.
  • Pipeline Expansion: $60B oncology/ophthalmology pipeline added via Nanjing Anji licensing.
  • Manufacturing Scale: U.S. capacity quadrupling to support 50% proprietary products by 2026.
  • Financial Challenges: 1.9% gross margin decline, $39.5M G&A spike due to litigation.
  • 2026 Outlook: High single to low double-digit growth, driven by AMP-007, AMP-015 launches.
EPS
Revenue

Revenue & Expenses

AMPH has released its 2025 Q3 earnings report, with revenue of 191.84M, reflecting a YoY change of 0.33%, and net profit of 17.35M, showing a YoY change of -57.09%. The Sankey diagram below clearly presents AMPH's revenue sources and cost distribution.

Key Indicators

Amphastar (AMPH) key financial stats and ratios, covering profitability, financial health, and leverage.
Amphastar (AMPH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Amphastar (AMPH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Amphastar (AMPH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Amphastar (AMPH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Amphastar (AMPH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield